Rocket Lab Backlog Went to the Moon. The Stock Is Down Anyway.

Rocket Lab beat expectations and grew its backlog by more than 50% quarter over quarter, yet the stock fell anyway. That disconnect between a strong print and a negative price reaction is the setup traders need to size up.

The source does not quantify the stock's decline, the size of the earnings beat, or the dollar value of the backlog. What it does establish is direction: better-than-expected financial results, backlog growth above 50% sequentially, and a down move in the shares despite both.

Interpretation, not reported fact: a sell-off on a beat plus accelerating backlog suggests the market had already priced in good news, or that investors are focused on factors beyond the headline numbers. The source gives no reason for the decline, so any specific explanation would be speculation.

Separately, the same Barron's item notes that Berkshire repurchased $9.6 billion of stock during the third quarter. Most of the buyback hit the more liquid Class B shares, while roughly $3.4 billion went toward Class A stock. That is a sizable buyback figure, though the source does not connect it to Rocket Lab or to any broader market move.